Nifty
Sensex
:
:
18726.40
63142.96
127.40 (0.69%)
350.08 (0.56%)

Pharmaceuticals & Drugs - Global

Rating :
36/99

BSE: 532300 | NSE: WOCKPHARMA

170.15
07-Jun-2023
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 176.80
  • 177.65
  • 169.55
  • 176.00
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  2553149
  •  4414.80
  •  282.55
  •  145.15

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,531.74
  • N/A
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 3,987.74
  • N/A
  • 0.75

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 59.31%
  • 3.31%
  • 31.45%
  • FII
  • DII
  • Others
  • 2.78%
  • 0.00%
  • 3.15%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -5.37
  • -3.88
  • -0.96

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -17.58
  • 176.92
  • 4.15

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -16.70
  • 52.19

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.01
  • 1.38
  • 1.23

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 57.24
  • 43.63
  • 35.26

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Var%
Dec 22
Dec 21
Var%
Sep 22
Sep 21
Var%
Jun 22
Jun 21
Var%
Net Sales
678.00
655.00
3.51%
699.00
854.00
-18.15%
679.00
862.00
-21.23%
595.00
860.00
-30.81%
Expenses
675.00
688.00
-1.89%
654.00
742.00
-11.86%
636.00
765.00
-16.86%
611.00
752.00
-18.75%
EBITDA
3.00
-33.00
-
45.00
112.00
-59.82%
43.00
97.00
-55.67%
-16.00
108.00
-
EBIDTM
0.44%
-5.04%
6.44%
13.11%
6.33%
11.25%
-2.69%
12.56%
Other Income
32.00
14.00
128.57%
2.00
1.00
100.00%
57.00
4.00
1,325.00%
57.00
14.00
307.14%
Interest
76.00
86.00
-11.63%
83.00
80.00
3.75%
70.00
69.00
1.45%
73.00
64.00
14.06%
Depreciation
56.00
59.00
-5.08%
66.00
62.00
6.45%
65.00
61.00
6.56%
64.00
64.00
0.00%
PBT
-193.00
-347.00
-
-105.00
-29.00
-
-230.00
-29.00
-
-96.00
-6.00
-
Tax
44.00
-36.00
-
-3.00
-31.00
-
-23.00
-66.00
-
-21.00
1.00
-
PAT
-237.00
-311.00
-
-102.00
2.00
-
-207.00
37.00
-
-75.00
-7.00
-
PATM
-34.96%
-47.48%
-14.59%
0.23%
-30.49%
4.29%
-12.61%
-0.81%
EPS
-14.44
-17.92
-
-6.67
-0.59
-
-13.13
2.85
-
-4.65
-1.09
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Net Sales
2,651.00
3,230.00
2,708.00
3,325.15
4,158.38
3,936.90
4,014.61
4,453.22
4,481.54
4,830.36
5,609.42
Net Sales Growth
-17.95%
19.28%
-18.56%
-20.04%
5.63%
-1.94%
-9.85%
-0.63%
-7.22%
-13.89%
 
Cost Of Goods Sold
1,111.00
1,267.00
1,135.00
1,203.45
1,636.31
1,797.53
1,662.07
1,613.68
1,487.48
1,806.25
1,747.56
Gross Profit
1,540.00
1,963.00
1,573.00
2,121.70
2,522.07
2,139.37
2,352.54
2,839.54
2,994.06
3,024.11
3,861.86
GP Margin
58.09%
60.77%
58.09%
63.81%
60.65%
54.34%
58.60%
63.76%
66.81%
62.61%
68.85%
Total Expenditure
2,576.00
2,932.00
2,771.00
3,082.03
4,050.63
3,935.07
3,988.39
3,958.98
3,772.14
3,804.65
3,549.74
Power & Fuel Cost
-
98.00
82.00
85.41
93.30
77.80
110.10
113.99
101.40
92.17
97.08
% Of Sales
-
3.03%
3.03%
2.57%
2.24%
1.98%
2.74%
2.56%
2.26%
1.91%
1.73%
Employee Cost
-
749.00
763.00
743.33
800.38
937.06
966.51
950.77
868.87
768.63
655.90
% Of Sales
-
23.19%
28.18%
22.35%
19.25%
23.80%
24.07%
21.35%
19.39%
15.91%
11.69%
Manufacturing Exp.
-
169.00
145.00
120.90
153.76
135.27
179.40
228.07
236.03
240.85
180.06
% Of Sales
-
5.23%
5.35%
3.64%
3.70%
3.44%
4.47%
5.12%
5.27%
4.99%
3.21%
General & Admin Exp.
-
224.00
251.00
186.55
380.13
476.66
504.43
405.85
320.92
352.19
248.28
% Of Sales
-
6.93%
9.27%
5.61%
9.14%
12.11%
12.56%
9.11%
7.16%
7.29%
4.43%
Selling & Distn. Exp.
-
180.00
132.00
141.18
176.22
208.89
205.30
241.11
261.55
292.98
291.74
% Of Sales
-
5.57%
4.87%
4.25%
4.24%
5.31%
5.11%
5.41%
5.84%
6.07%
5.20%
Miscellaneous Exp.
-
245.00
263.00
601.21
810.53
301.86
360.58
405.51
495.89
251.58
291.74
% Of Sales
-
7.59%
9.71%
18.08%
19.49%
7.67%
8.98%
9.11%
11.07%
5.21%
5.87%
EBITDA
75.00
298.00
-63.00
243.12
107.75
1.83
26.22
494.24
709.40
1,025.71
2,059.68
EBITDA Margin
2.83%
9.23%
-2.33%
7.31%
2.59%
0.05%
0.65%
11.10%
15.83%
21.23%
36.72%
Other Income
148.00
20.00
132.00
60.08
21.02
120.23
100.83
66.10
66.55
38.40
54.00
Interest
302.00
299.00
249.00
275.74
265.14
255.49
225.27
128.96
55.21
83.35
215.37
Depreciation
251.00
247.00
246.00
224.14
163.95
149.53
148.93
141.91
145.40
139.92
122.14
PBT
-624.00
-228.00
-426.00
-196.68
-300.32
-282.96
-247.15
289.47
575.34
840.84
1,776.17
Tax
-3.00
-132.00
-271.00
-153.29
-83.66
25.70
-21.11
37.88
162.65
47.88
258.21
Tax Rate
0.48%
32.12%
47.71%
77.94%
27.86%
-4.01%
8.54%
13.09%
28.27%
5.38%
14.05%
PAT
-621.00
-244.00
-299.00
-69.22
-194.53
-608.30
-195.72
250.08
404.91
840.72
1,579.48
PAT before Minority Interest
-560.00
-279.00
-297.00
-43.39
-216.66
-666.85
-226.04
251.59
412.69
842.79
1,579.48
Minority Interest
61.00
35.00
-2.00
-25.83
22.13
58.55
30.32
-1.51
-7.78
-2.07
0.00
PAT Margin
-23.43%
-7.55%
-11.04%
-2.08%
-4.68%
-15.45%
-4.88%
5.62%
9.04%
17.40%
28.16%
PAT Growth
0.00%
-
-
-
-
-
-
-38.24%
-51.84%
-46.77%
 
EPS
-43.10
-16.93
-20.75
-4.80
-13.50
-42.21
-13.58
17.35
28.10
58.34
109.61

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Shareholder's Funds
3,849.00
3,376.00
2,671.67
2,674.80
2,852.15
3,336.71
3,775.12
3,715.35
3,581.47
2,704.18
Share Capital
72.00
55.00
55.37
55.34
55.32
55.27
55.25
353.59
353.43
353.34
Total Reserves
3,759.00
3,293.00
2,586.33
2,587.19
2,760.11
3,244.43
3,691.22
3,315.65
3,182.73
2,319.30
Non-Current Liabilities
261.00
496.00
1,194.85
1,702.75
2,088.89
3,151.38
1,893.49
1,872.46
1,161.18
1,520.80
Secured Loans
260.00
500.00
1,237.44
1,653.25
2,167.84
2,887.11
1,647.34
1,180.25
1,096.27
1,467.51
Unsecured Loans
95.00
3.00
3.46
238.22
5.27
303.16
273.26
4.59
6.03
7.64
Long Term Provisions
32.00
84.00
45.60
53.48
64.89
94.23
70.74
635.05
51.98
69.85
Current Liabilities
3,207.00
3,121.00
3,497.18
2,863.66
2,691.71
1,978.81
1,841.85
1,772.97
1,743.20
1,773.48
Trade Payables
921.00
696.00
895.27
840.24
601.78
533.81
637.69
552.56
557.79
634.15
Other Current Liabilities
1,197.00
1,230.00
1,579.80
1,353.09
1,548.13
690.13
621.23
844.44
947.70
789.96
Short Term Borrowings
1,034.00
1,066.00
903.86
561.71
437.09
662.80
550.03
348.28
210.20
182.00
Short Term Provisions
55.00
129.00
118.25
108.62
104.71
92.07
32.90
27.69
27.51
167.37
Total Liabilities
7,670.00
7,376.00
7,749.49
7,571.04
7,978.48
8,848.84
7,975.79
7,504.73
6,622.02
5,998.46
Net Block
3,462.00
3,343.00
3,502.29
3,057.93
2,887.96
2,772.55
2,808.70
2,122.74
2,294.63
1,989.60
Gross Block
6,019.00
5,656.00
6,703.28
6,112.89
5,772.29
5,456.40
4,377.01
4,552.96
4,642.81
4,295.75
Accumulated Depreciation
2,557.00
2,313.00
3,200.99
3,054.96
2,884.33
2,683.85
1,568.31
2,430.22
2,348.18
1,684.94
Non Current Assets
5,081.00
4,951.00
5,319.66
4,756.39
4,598.88
4,313.57
4,023.94
3,983.17
3,266.10
2,671.53
Capital Work in Progress
1,342.00
1,379.00
1,584.53
1,445.48
1,432.57
1,243.95
1,036.05
1,007.30
707.53
490.94
Non Current Investment
0.00
0.00
0.45
0.45
0.45
0.45
0.45
2.62
2.62
2.63
Long Term Loans & Adv.
259.00
228.00
230.63
252.37
277.90
296.62
178.74
845.68
235.86
183.35
Other Non Current Assets
18.00
1.00
1.76
0.16
0.00
0.00
0.00
4.83
25.46
5.01
Current Assets
2,589.00
2,425.00
2,429.83
2,814.65
3,379.60
4,535.27
3,951.85
3,521.56
3,355.92
3,326.93
Current Investments
0.00
0.00
0.00
0.00
213.25
562.27
0.00
338.72
573.98
0.00
Inventories
769.00
799.00
689.83
819.36
855.71
1,107.95
1,102.16
1,020.78
992.89
1,058.83
Sundry Debtors
918.00
918.00
1,242.69
1,273.90
962.45
1,034.45
1,111.42
741.43
481.04
958.46
Cash & Bank
406.00
292.00
268.46
448.65
1,082.25
1,603.61
1,478.11
1,234.55
1,125.80
1,096.06
Other Current Assets
496.00
144.00
56.64
20.18
265.94
226.99
260.16
186.08
182.21
213.58
Short Term Loans & Adv.
352.00
272.00
172.21
252.56
257.63
197.75
260.16
186.08
182.21
213.58
Net Current Assets
-618.00
-696.00
-1,067.35
-49.01
687.89
2,556.46
2,110.00
1,748.59
1,612.72
1,553.45
Total Assets
7,670.00
7,376.00
7,749.49
7,571.04
7,978.48
8,848.84
7,975.79
7,504.73
6,622.02
5,998.46

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Cash From Operating Activity
413.00
-287.00
648.96
183.32
68.44
-269.47
71.61
354.96
1,476.29
1,532.40
PBT
-411.00
916.00
-196.68
-300.32
-641.15
-247.15
357.01
575.34
890.67
1,860.20
Adjustment
554.00
-943.00
483.23
444.52
448.78
303.04
201.29
285.63
133.53
273.31
Changes in Working Capital
367.00
-143.00
379.58
80.29
278.33
-297.39
-402.76
-344.62
587.99
-266.99
Cash after chg. in Working capital
510.00
-170.00
666.13
224.49
85.96
-241.50
155.54
516.35
1,612.19
1,866.52
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-97.00
-117.00
-17.17
-41.17
-17.52
-27.97
-83.93
-161.39
-135.90
-334.12
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-201.00
1,470.00
-155.53
94.57
630.24
-686.64
-818.19
-206.63
-851.62
1,085.37
Net Fixed Assets
-416.00
-200.42
-499.84
-39.00
-45.55
-166.75
-368.17
-299.87
-283.99
174.15
Net Investments
0.00
0.27
0.00
-0.05
0.00
0.00
0.00
10.73
0.00
0.00
Others
215.00
1,670.15
344.31
133.62
675.79
-519.89
-450.02
82.51
-567.63
911.22
Cash from Financing Activity
-71.00
-1,171.00
-679.58
-776.45
-769.47
1,254.49
254.26
-75.65
-601.32
-2,245.75
Net Cash Inflow / Outflow
141.00
12.00
-186.15
-498.56
-70.79
298.38
-492.32
72.68
23.35
372.02
Opening Cash & Equivalents
232.00
219.00
397.34
897.24
963.64
662.98
1,158.69
1,101.65
1,050.01
689.66
Closing Cash & Equivalent
370.00
232.00
219.34
397.34
897.24
963.64
664.64
1,158.69
1,101.65
1,050.01

Financial Ratios

Consolidated /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Book Value (Rs.)
266.04
280.48
238.55
238.75
254.47
298.51
339.05
306.20
294.97
216.65
ROA
-3.71%
-3.93%
-0.57%
-2.79%
-7.93%
-2.69%
3.25%
6.09%
13.36%
25.78%
ROE
-7.77%
-9.92%
-1.64%
-7.94%
-21.81%
-6.42%
7.07%
12.49%
30.04%
102.78%
ROCE
-1.96%
-5.50%
1.32%
-0.56%
-5.47%
-0.31%
6.87%
11.25%
18.98%
43.10%
Fixed Asset Turnover
0.88
0.75
0.52
0.70
0.70
0.82
1.00
0.98
1.08
1.32
Receivable days
65.29
85.04
138.12
98.15
92.57
97.55
75.93
49.71
54.33
55.81
Inventory Days
55.76
58.60
82.83
73.51
91.03
100.47
87.00
81.88
77.43
63.29
Payable days
232.91
255.87
129.66
86.65
67.29
64.08
64.54
63.71
65.00
65.49
Cash Conversion Cycle
-111.86
-112.23
91.29
85.01
116.31
133.94
98.39
67.88
66.75
53.61
Total Debt/Equity
0.49
0.70
1.22
1.28
1.33
1.26
0.71
0.55
0.54
0.77
Interest Cover
-0.37
-1.28
0.29
-0.13
-1.51
-0.10
3.24
11.42
11.69
9.53

News Update:


  • Wockhardt planning to roll out two vaccines within year from UK-based facility
    27th Feb 2023, 12:46 PM

    Serum has identified two vaccines and the company plans to manufacture these products within the next 12 months

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.